https://pharmacypractice.org/journal/index.php/pp/issue/feed Pharmacy Practice 2019-11-05T16:25:19+00:00 Fernando Fernandez-Llimos journal@pharmacypractice.org Open Journal Systems <p><strong>Pharmacy Practice</strong> is a free full-text peer-reviewed journal with a scope on pharmacy practice. <strong>Pharmacy Practice</strong> is published quarterly. <strong>Pharmacy Practice <span style="text-decoration: underline; color: #ff0000;">does not charge any publication fee to the author</span><span style="text-decoration: underline;"><span style="color: #ff0000; text-decoration: underline;">s</span></span></strong>.</p> https://pharmacypractice.org/journal/index.php/pp/article/view/1541 Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit 2019-10-31T10:41:30+00:00 Ali Scrimenti scrimena@upstate.edu Robert W. Seabury seaburyr@upstate.edu Christopher D. Miller millechr@upstate.edu Lucy Ruangvoravat ruangvol@upstate.edu William Darko darkow@upstate.edu Luke A. Probst probstl@upstate.edu Gregory M. Cwikla cwiklag@upstate.edu <p><strong>Background</strong>: There is limited information describing pharmacist participation in prophylactic enoxaparin monitoring in the surgical intensive care unit (SICU).</p> <p><strong>Objective</strong>: Our study sought to: 1) characterize pharmacist recommendations for enoxaparin monitoring in trauma patients admitted to the SICU, 2) describe the frequency that medical providers accept pharmacist recommendations for enoxaparin monitoring in trauma patients admitted to the SICU, and 3) illustrate the frequency that trauma patients admitted to our SICU service achieve anti-factor Xa trough concentrations (AFXa-TRs) of 0.11 - 0.20 IU/mL following pharmacist recommendation to adjust prophylactic enoxaparin dosing.</p> <p><strong>Methods</strong>: Adult patients who had an AFXa-TR drawn after at least three consecutive prophylactic enoxaparin doses between June 1, 2017 and March 1, 2018 were identified through chart review and included in this study. Patients were excluded based on the following criteria: 1) age less than 18 years, 2) anti-factor Xa (AFXa) level not representative of a trough concentration, 3) AFXa-TR not representative of steady state concentration, and 4) non-trauma based prophylactic enoxaparin dosing.&nbsp; This study was exempt from IRB review.</p> <p><strong>Results</strong>: The final analysis consisted of 42 patients. A pharmacist provided at least one recommendation in 97.6% (41/42) of trauma patients with enoxaparin monitoring during their SICU stay. In total, a pharmacist made 170 recommendations, mean of 4.2 (SD 1.8) recommendations per patient. Recommendations were: 1) obtain an AFXa-TR, n=90; 2) adjust enoxaparin dose based on AFXa-TR, n=58; and 3) maintain enoxaparin dose based on AFXa-TR, n=22. Medical providers accepted 89.4% (152/170) of pharmacist recommendations for enoxaparin monitoring. Dose adjustments were made in 33 patients following pharmacist recommendation; of these, 27 had a repeat AFXa-TR following at least one dose adjustment. Target AFXa-TRs were achieved in 19/27 patients, indicating 70.4% had recommended AFXa concentrations.</p> <p><strong>Conclusions</strong>: Pharmacists provided recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to the SICU. Medical providers regularly accepted pharmacist recommendations and trauma patients commonly achieved target AFXa-TR following pharmacist recommendation for dose adjustment. Further research is required to identify the optimal enoxaparin dose for VTE prophylaxis in trauma patients.</p> 2019-10-31T10:41:29+00:00 Copyright (c) 2019 Pharmacy Practice and the Authors https://pharmacypractice.org/journal/index.php/pp/article/view/1590 Drug and therapeutics committees in Jordanian hospitals: a nation-wide survey of organization, activities, and drug selection procedures 2019-11-05T16:25:19+00:00 Qais Alefan qmefan@just.edu.jo Somayya Alshareef somaya_alsharif@yahoo.com Samah Al-Shatnawi sfshatnawi@just.edu.jo <p><strong>Background</strong>: Drug and Therapeutics Committees (DTCs) were founded about a century ago as a guide for dealing with drugs in hospitals. Since then, it has shown a vital role in rational drug use in terms of regulatory and educational activities.</p> <p><strong>Objective</strong>: To describe structures, functions, and activities of hospital DTCs.&nbsp;</p> <p><strong>Methods</strong>: A questionnaire was developed based on previous studies. Questions consisted of information on respondents’ demographics; structures, functions, and activities of DTCs; drug selection process and resources used, and factors and criteria used in drug selection.</p> <p><strong>Results</strong>: The overall response rate was 95%. DTCs were mainly present in most large hospitals (45%). All DTCs had hospital pharmacists in their structure and most of them (66%) met monthly. The main responsibilities of DTCs were related to general prescribing policies. The number, frequency, and severity of adverse drug reactions were the most reported criteria for the drug selection process. Legal implications for practical, economic, and organizational factors were the most important factors that were reported for drug selection.&nbsp;</p> <p><strong>Conclusions</strong>: DTCs are mainly present in most large hospitals. The main responsibilities of the DTC in Jordanian hospitals are general prescribing policies, drug selection, hospital formulary editing, and reporting of ADR to external authorities.</p> 2019-11-03T17:11:48+00:00 Copyright (c) 2019 Pharmacy Practice and the Authors https://pharmacypractice.org/journal/index.php/pp/article/view/1613 Factors associated with quality of life among community pharmacists in Lebanon: results of a cross-sectional study 2019-10-28T19:12:00+00:00 Hala Sacre halasacre@hotmail.com Sahar Obeid saharobeid23@hotmail.com Georges Choueiry georgecymail@gmail.com Eva Hobeika eva.hobeika@hotmail.com Rita Farah ritafarah15@gmail.com Aline Hajj aline.hajj@hotmail.com Marwan Akel marwan.akel@liu.edu.lb Souheil Hallit souheilhallit@hotmail.com Pascale Salameh pascalesalameh1@hotmail.com <p><strong>Objective</strong>: The objective of this study was to assess the quality of life and the factors associated with it among community pharmacists in Lebanon.</p> <p><strong>Methods</strong>: This cross-sectional study was carried out between March and July 2018, enrolling 435 pharmacists, using a proportionate random sample of community pharmacies from all districts of Lebanon. The validated Arabic translation of the Short-Form 12 (SF12v2) was used to derive 2 summary scores: physical and mental component summaries (PCS and MCS).</p> <p><strong>Results</strong>: Lebanese community pharmacists scored a mean PCS-12 and MCS-12 of 48.9 (SD 7.1) and 48.8 (SD 8.5), respectively. Higher age (Beta= -0.08), having a PhD degree (Beta= -4.54), higher depression score (Beta= -0.25), higher emotional work fatigue (Beta= -0.13) and higher physical work fatigue (Beta=-0.14) were significantly associated with lower physical QoL (lower PCS-12 scores).</p> <p>Increased stress (Beta= -0.17), higher insomnia (Beta= -0.21), higher depression (Beta= -0.2) and working for over 40 hours per week (Beta= -0.2) were significantly associated with lower mental QoL (lower mental MCS-12 scores).</p> <p><strong>Conclusions</strong>: Our research has found a strong correlation between quality of life and psychological factors, including stress, burnout, insomnia, and depression among community pharmacists.</p> 2019-10-28T18:59:52+00:00 Copyright (c) 2019 Pharmacy Practice and the Authors